Johnson & Johnson JNJ

$255.00 +1.72 (0.68%)

Valuation

Market cap
611,897,216,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
PE ratio
23.34
Forward PE
22.40
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
4,260,172
Avg volume
6,820,464
Day's range
$254.00 – $257.55
Shares out
2,409,898,000
Stochastic %K
42%
Beta
0.21
Analysts
Strong Sell
Price target
$281.76

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

chursinow62 Oct 16, 6:33 PM
$JNJ Rotation into JNJ from tech wreck sell off
0 replies
Gebinator Oct 16, 4:25 PM
$SLS isn't it remarkable that $JNJ, $MRK, $ABBV, $LLY and other BPs are still green 🍏 today? $40 Billy 🦖 MINIMUM
0 replies
thatsolardude365 Oct 16, 3:34 PM
$JNJ: the talc MDL fight is now also about who leads it. On May 26 the court denied Beasley Allen's bid to stay its disqualification. 68,029 cases remain in MDL 2738, no settlement, nothing to claim. Open Class Actions.
0 replies
chursinow62 Oct 16, 2:07 PM
$JNJ $258 print
0 replies
chursinow62 Oct 16, 2:01 PM
$JNJ Institutions bidding this up🚀🚀🚀🚀🚀
0 replies
chursinow62 Oct 16, 1:58 PM
$JNJ LOAD LIKE the BIGBOYS
0 replies
chursinow62 Oct 16, 1:57 PM
$JNJ Tech trade is going to fall off a cliff. JNJ is where the money flow is going to go . 19 new drugs in there pipeline 😘
0 replies
Baddb Oct 16, 1:23 PM
$JNJ 258 then down again 🤔✌️
0 replies